Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells

Journal of Cellular Physiology

Volumn 217, Issue 3, 2008, Pages 569-576

  Yang, Huanjie ^a   Murthy, Shalini ^b   Sarkar, Fazlul H ^a   Sheng, Shijie ^a   Reddy, G Prem Veer ^a,b,c   Dou, Q Ping ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ANDROGEN RECEPTOR; CALMODULIN; CALPAIN; CALPASTATIN; CELASTROL; DOCETAXEL; ETOPOSIDE; MESSENGER RNA; N ACETYLLEUCYLLEUCYLMETHIONINAL; PD 15060; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG; AR PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEINASE INHIBITOR; TRANSACTIVATOR PROTEIN; TRIPTERINE; TRITERPENE;

ADVANCED CANCER; ANDROGEN SYNTHESIS; APOPTOSIS; ARTICLE; CANCER HORMONE THERAPY; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; RECEPTOR DOWN REGULATION; CELL FREE SYSTEM; CYTOSOL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOLECULAR WEIGHT; PATHOLOGY; PROSTATE TUMOR; PROTEIN BINDING; PROTEIN PROCESSING; TUMOR CELL LINE;

APOPTOSIS; CALMODULIN; CALPAIN; CELL LINE, TUMOR; CELL-FREE SYSTEM; CYTOSOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPES SIMPLEX VIRUS PROTEIN VMW65; HUMANS; MALE; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ANDROGEN; TRITERPENES;

EID: 54049150008     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21565     Document Type: Article

References (46)

1. An B, Dou QP. 1996. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res 56:438-442.
2. Carafoli E, Molinari M. 1998. Calpain: A protease in search of a function? Biochem Biophys Res Commun 247:193-203.
3. Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, Wang C, Mizokami A. 1995. Androgen receptor: An overview. Crit Rev Eukaryot Gene Expr 5:97-125.
4. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat Med 10:33-39.
5. Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP. 2007. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res 67:1636-1644.
6. Cifuentes E, Mataraza JM, Yoshida BA, Menon M, Sacks DB, Barrack ER, Reddy GP. 2004. Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells. Proc Natl Acad Sci USA 101:464-469.
7. Culig Z. 2004. Androgen receptor cross-talk with cell signalling pathways. Growth factors 22:179-184.
8. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. 1994. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478.
9. Daniel KG, Anderson JS, Zhong Q, Kazi A, Gupta P, Dou QP. 2003. Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis. Int J Mol Med 12:247-252.
10. de Boer W, Bolt J, Kuiper GG, Brinkmann AO, Mulder E. 1987. Analysis of steroid- and DNA-binding domains of the calf uterine androgen receptor by limited proteolysis. J Steroid Biochem 28:9-19.
11. Dice JF. 1987. Molecular determinants of protein half-lives in eukaryotic cells. FASEB J 1:349-357.
12. Gao G, Dou QP. 2000. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem 80:53-72.
13. Heinlein CA, Chang C. 2004. Androgen receptor in prostate cancer. Endocr Rev 25:276-308.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007. CA Cancer J Clin 57:43-66.
15. Jia L, Shen HC, Wantroba M, Khalid O, Liang G, Wang Q, Gentzschein E, Pinski JK, Stanczyk FZ, Jones PA, Coetzee GA. 2006. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol 26:7331-7341.
16. Kaku N, Matsuda KI, Tsujimura A, Kawata M. 2008. Characterization of nuclear import of the domain-specific androgen receptor in association with the importin α/β and Ran-GTP systems. Endocrinology 149:3960-3969.
17. Kobayashi Y, Miwa S, Merry DE, Kume A, Mei L, Doyu M, Sobue G. 1998. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner. Biochem Biophys Res Commun 252:145-150.
18. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
19. Lee DK, Chang C. 2003. Endocrine mechanisms of disease: Expression and degradation of androgen receptor: Mechanism and clinical implication. J Clin Endocrinol Metab 88:4043-4054.
20. Libertini SJ, Tepper CG, Rodriguez V, Asmuth DM, Kung HJ, Mudryj M. 2007. Evidence for capain-mediated androgen receptor cleavage as a mechanism for androgen independence. Cancer Res 67:9001-9005.
21. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. 2002. Phosphorylation- dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 21:4037-4048.
22. Lotem J, Sachs L. 1996. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc Natl Acad Sci USA 93:12507-12512.
23. Nakagawa K, Masumoto H, Sorimachi H, Suzuki K. 2001. Dissociation of m-calpain subunits occurs after autolysis of the N-terminus of the catalytic subunit, and is not required for activation. J Biochem 130:605-611.
24. Nam S, Smith DM, Dou QP. 2001. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276:13322-13330.
25. Pang H, Chen D, Cui QC, Dou QP. 2007. Sodium diethyldithiocarbamate, an AIDS progression inhibitor and a copper-binding compound, has proteasome-inhibitory and apoptosis-inducing activities in cancer cells. Int J Mol Med 19:809-816.
26. Pelley RP, Chinnakannu K, Murthy S, Strickland FM, Menon M, Dou QP, Barrack ER, Reddy GP. 2006. Calmodulin-androgen receptor (AR) interaction: Calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells. Cancer Res 66:11754-11762.
27. Pink JJ, Wuerzberger-Davis S, Tagliarino C, Planchon SM, Yang X, Froelich CJ, Boothman DA. 2000. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during beta-lapachone-mediated apoptosis. Exp Cell Res 255:144-155.
28. Ray SK, Hogan EL, Banik NL. 2003. Calpain in the pathophysiology of spinal cord injury: Neuroprotection with calpain inhibitors. Brain Res Rev 42:169-185.
29. Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S. 2006. Regulatory processes affecting androgen receptor expression, stability, and function: Potential targets to treat hormone-refractory prostate cancer. J Cell Biochem 98:1408-1423.
30. Sareen D, Darjatmoko SR, Albert DM, Polans AS. 2007. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 72:1466-1475.
31. Schaufele F, Carbonell X, Guerbadot M, Borngraeber S, Chapman MS, Ma AA, Miner JN, Diamond MI. 2005. The structural basis of androgen receptor activation: Intramolecular and intermolecular amino-carboxy interactions. Proc Natl Acad Sci USA 102:9802-9807.
32. Sheflin L, Keegan B, Zhang W, Spaulding SW. 2000. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun 276:144-150.
33. Suzuki K, Sorimachi H. 1998. A novel aspect of calpain activation. FEBS Lett 433:1-4.
34. Suzuki K, Hata S, Kawabata Y, Sorimachi H. 2004. Structure, activation, and biology of calpain. Diabetes 53:S12-S18.
35. Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, Yoshioka H, Daigo Y, Nasu Y, Kumon H, Konaka H, Namiki M, Tozawa K, Kohri K, Tanji N, Yokoyama M, Shimazui T, Akaza H, Mizutani Y, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H. 2007. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res 67:5117-5125.
36. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M. 2004. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64:7156-7168.
37. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, Rowland KJ, Zhang T, Rasper D, Roy S, Thornberry N, Pinsky L, Kakizuka A, Ross CA, Nicholson DW, Bredesen DE, Hayden MR. 1998. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158-9167.
38. Wilkinson KD. 1999. Ubiqitin-dependent signaling: The role of ubiquitination in the response of cells to their environment. J Nutr 129:1933-1936.
39. Wilson EM, French FS. 1979. Effects of proteases and protease inhibitors on the 4.5 S and 8 S androgen receptor. J Biol Chem 254:6310-6319.
40. Wood DE, Newcomb EW. 1999. Caspase-dependent activation of calpain during drug-induced apoptosis. J Biol Chem 274:8309-8315.
41. Wood DE, Thomas A, Devi LA, Berman Y, Beavis RC, Reed JC, Newcomb EW. 1998. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17:1069-1078.
42. Yang H, Chen D, Cui QC, Yuan X, Dou QP. 2006. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res 66:4758-4765.
43. Yang H, Shi G, Dou QP. 2007. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry". Mol Pharmacol 71:426-437.
44. Yang H, Landis-Piwowar KR, Lu D, Yuan P, Li L, Reddy GP, Yuan X, Dou QP. 2008. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. J Cell Biochem 103:234-244.
45. Zhou ZX, Sar M, Simental JA, Lane MV, Wilson EM. 1994. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J Biol Chem 269:13115-13123.
46. Zimmerman UJ, Schlaepfer WW. 1982. Characterization of a brain calcium-activated protease that degrades neurofilament proteins. Biochemistry 21:3977-3982.